SIMAP

SIMAP will develop a simulation model of the cancer related MAP-kinase pathway, integrating and analyzing data from various types of resources, which may assist in the development of better cancer treatment.

The completion of the human genome gave hope for a new age of medical understanding, but 4-5 years later costs of drug development are still rising and the success rate has not improved. Drugs that have already hit the market are found to have major side effects not perceived in the past and are often given to patients without discrimination on their likeliness to respond.

Large scale methodologies that thrive in recent years, allowed the industry and academia to gather more information on RNAs and proteins. However, the understanding of the molecular and cellular processes is still lacking, not to mention the connection to the clinical outcome. In order to fully use this data, a comprehensive integration and modelling effort is needed. A systematic rational hypothesis-driven research approach connecting all those levels of information is a much needed computational tool. This is the main goal of SIMAP project.

The ultimate goal of SIMAP is to develop a comprehensive simulation biochemical model of EGFRMAP kinase pathway in connection to cancer clinical information. SIMAP will:

  • Incorporate low-level biochemical modelling of individual molecules;
  • Simulate the behaviour of the pathway;
  • Add genomic and proteomic data;
  • Incorporate individual patients’ responses; and
  • Analyze sub population of responses in the context of the biochemical behaviour and genotype data

For further information, please visit:
http://www.simap-project.org

Project co-ordinator:
Compugen Ltd.

Partners:

  • Aureus Pharma, (FR)
  • Compugen Ltd., (IL)
  • Consejo Superior de Investigaciones Científicas, (ES)
  • Halevi Dweck & Co.Arttic Israel Company Ltd., (IL)
  • Fundacio Institut De Recerca De L'Hospital Universitari Vall D'Hebron, (ES)
  • Fondazione IRCCS Istituto Nazionale Dei Tumori, (IT)
  • The Max-Planck Institute for Infection Biology, (DE)
  • The University of Glasgow, (UK)
  • The Weizmann Institute of Science, (IL)

Timetable: from 01/06 – to 12/08

Total cost: € 4.464.201

EC funding: € 3.126.662

Instrument: STREP

Project Identifier: IST-2004-027265

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

Alcon to Develop SMART Suite Digital Hea…

Alcon, the global leader in eye care and a division of Novartis, today announced plans to develop the SMART Suite by Alcon, an innovative, digital platform that is designed to...

Philips Launches First Global Start-Up C…

Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, announced the launch of its first global start-up collaboration program involving Philips' innovation hubs in Cambridge (US), Eindhoven...

Simple Stickers may Save Lives of Patien…

Heart surgery can be traumatic for patients. Having to continuously monitor your status without a doctor when you are back home can be even scarier. Imagine being able to do...

Digital Health Consultancy Expands to Su…

Digital health consultancy Populo Consulting has announced the appointment of a new managing director as part of an ambitious growth strategy. The expansion will enable it to support more NHS...

MEDICA 2018 Boasts over 5,000 Exhibitors…

12 - 15 November 2018, Düsseldorf, Germany. When top decision-makers in the healthcare business meet in Düsseldorf in the middle of November at the world's leading medical trade fair, MEDICA 2018...

Stanford, Apple Describe Heart Study wit…

A clinical trial to determine whether a smartwatch app that analyzes pulse-rate data can screen for a heart-rhythm disorder has enrolled more than 400,000 participants. Researchers at Stanford Medicine, in...

With Mobilett Elara Max, Siemens Healthi…

With the presentation of Mobilett Elara Max, Siemens Healthineers is setting new standards in mobile X-ray imaging. The easy-to-clean system surfaces with an antimicrobial coating reduce the risk of hospital...

Augmented Reality may Assist Cardiologis…

Augmented reality (AR), a technology that superimposes computer-generated information on a user's view of the real world, offers a new platform to help physicians better visualize complex medical data, particularly...

The Partnership for Digital Healthis Com…

15 - 16 November 2018, Berlin, Germany. The initiative co-founded by Egon Zehnder and including partners Sanofi, SAP and Qiagen, is one of the most forward-thinking partnerships for promoting innovation in...

Health Tech Communications Agency Takes …

Highland Marketing, a full service marketing communications agency for the health tech and wider public sector markets, has appointed Michelle Cheng as marketing executive to support the business' rapid growth.

IBM to Acquire Red Hat, Completely Chang…

IBM (NYSE:IBM) and Red Hat (NYSE:RHT), the world's leading provider of open source cloud software, announced that the companies have reached a definitive agreement under which IBM will acquire all...